BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Helix Biopharma Corp. 

3-305 Industrial Parkway

Aurora  Ontario  L4G 6X7  Canada
Phone: 905-841-2300-Ext-232 Fax: 905-841-2244


SEARCH JOBS


Industry
Biotechnology

Segment
Vaccines





 Company News
Helix Biopharma (CC:HBP) Receives U.S. FDA Approval To Initiate A Clinical Trial Of L-DOS47 In Combination With Pemetrexed And Carboplatin 4/22/2014 8:45:41 AM    More...
Helix Biopharma (CC:HBP) Initiates Enrollment For Eighth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 4/8/2014 10:24:35 AM    More...
Helix Biopharma (CC:HBP) Submits L-DOS47 Investigational New Drug Application With FDA 4/4/2014 10:09:19 AM    More...
Helix Biopharma (CC:HBP) Announces Fiscal Q2 2014 Results 3/17/2014 11:02:10 AM    More...
Helix Biopharma (CC:HBP) Announces Appointment Of New Director And Observer To The Board of Directors 3/12/2014 10:11:38 AM    More...
Helix Biopharma (CC:HBP) Initiates Enrollment For Seventh Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 2/19/2014 10:45:34 AM    More...
Helix Biopharma (CC:HBP) Initiates Enrollment For Sixth Cohort In Polish Phase I/II Clinical Study Of Its Lung Cancer Drug Candidate L-DOS47 1/23/2014 10:12:52 AM    More...
Director of Helix Biopharma (CC:HBP) Acquires A Further 1,000,000 Common Shares 1/13/2014 9:19:26 AM    More...
Helix Biopharma (CC:HBP) Announces The Results Of Its Annual General And Special Meeting 12/19/2013 10:25:11 AM    More...
Helix Biopharma (CC:HBP) Announces Director Resignation 12/17/2013 10:27:33 AM    More...
12345678910...

//-->